In addition, other studies on IBD patients highlighted the effectiveness of a second vaccination against other pathogens, such as influenza and hepatitis A [37,38], showing that vaccine effectiveness after the second vaccination even in patients on anti TNF agents is not attenuated compared to healthy controls. This evidence concerns the gene TNF and influenza.